GNCA - Genocea Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Genocea Biosciences's activity chart (see below) currently has 27 price targets and 32 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.83% with an average time for these price targets to be met of 76.5 days.

Most recent stock forecast was given by from WELLS FARGO on 29-Apr-2022. First documented stock forecast 05-Mar-2014.

Best performing analysts who are covering GNCA - Genocea Biosciences:

Edward Tenthoff Gil Blum

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Jul-2019

$0.16

$0.16 (0.00%)

$13

4 years 5 months 4 days ago
(29-Apr-2022)

1/2 (50%)

$-0.12 (-42.86%)

25

Buy Since 28-Feb-2019

$9

4 years 5 months 4 days ago
(29-Apr-2022)

2/4 (50%)

$8.4 (1400.00%)

12

Hold Since 29-Apr-2022

$0.16

$0.16 (0.00%)

4 years 5 months 4 days ago
(29-Apr-2022)

1/2 (50%)

$-0.12 (-42.86%)

25

Buy Since 15-Nov-2021

$6

$6 (0.00%)

$6

4 years 5 months 27 days ago
(06-Apr-2022)

0/2 (0%)

$4.74 (376.19%)

Buy Since 30-Jul-2020

$6

$6 (0.00%)

$7

5 years 7 months 22 days ago
(11-Feb-2021)

0/2 (0%)

$2.72 (82.93%)

Show more analysts

Please expand the browser size to see the chart

What is GNCA (Genocea Biosciences) average time for price targets to be met?

On average it took 77 days for the stock forecasts to be reached, with an average price target met ratio of 32.83%.

Which analyst most recently updated their price target on GNCA (Genocea Biosciences)?

Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?

has 0 price targets and 0 ratings on GNCA

Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?

Christopher James with the highest potential upside of $136

Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?

Joseph Pantginis with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?